Article
CLDN6 promotes chemoresistance through GSTP1 in human breast cancer
7 Nov 2017
Abstract excerpt
BACKGROUND: Claudin-6 (CLDN6), a member of CLDN family and a key component of tight junction, has been reported to function as a tumor suppressor in breast cancer. However, whether CLDN6 plays any role in breast cancer chemoresistance remains unclear. In this study, we investigated the role of CLDN6 in the acquisition of chemoresistance in breast cancer cells. METHODS: We manipulated the expression of CLDN6 in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
